Statistics
Modeling of HIV-1 prophylactic efficacy and toxicity with islatravir shows non-superiority for oral dosing, but promise as a subcutaneous implant
| Views | |
|---|---|
| Modeling ... | 13 |
Total Visits Per Month
| October 2025 | November 2025 | December 2025 | January 2026 | February 2026 | March 2026 | April 2026 | |
|---|---|---|---|---|---|---|---|
| Modeling ... | 0 | 0 | 0 | 0 | 0 | 0 | 13 |
File Visits
| Views | |
|---|---|
| CPT Pharmacom Syst Pharma - 2024 - Kim - Modeling of HIV‐1 prophylactic efficacy and toxicity with islatravir shows.pdf | 3 |